Satoru Takashima

491 total citations
18 papers, 376 citations indexed

About

Satoru Takashima is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Satoru Takashima has authored 18 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Molecular Biology and 5 papers in Epidemiology. Recurrent topics in Satoru Takashima's work include Immunotherapy and Immune Responses (4 papers), Immune Cell Function and Interaction (3 papers) and Neuroendocrine Tumor Research Advances (2 papers). Satoru Takashima is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), Immune Cell Function and Interaction (3 papers) and Neuroendocrine Tumor Research Advances (2 papers). Satoru Takashima collaborates with scholars based in Japan, Canada and United Kingdom. Satoru Takashima's co-authors include Hideyuki Ikematsu, Takeshi Noshi, Takeki Uehara, M.C.M. de Jong, Frederick G. Hayden, Keiko Kawaguchi, Nelson Lee, Masahiro Kinoshita, Kenji J. Tsuchiya and Yukio Hitotsuyanagi and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Satoru Takashima

15 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Satoru Takashima Japan 9 172 97 69 66 48 18 376
Caroline T. Seebauer Germany 8 204 1.2× 168 1.7× 57 0.8× 33 0.5× 42 0.9× 16 448
Satoshi Tsunematsu Japan 14 126 0.7× 190 2.0× 71 1.0× 19 0.3× 45 0.9× 35 435
Hitendra S. Solanki United States 13 266 1.5× 52 0.5× 80 1.2× 53 0.8× 61 1.3× 26 478
José Ortiz United States 8 121 0.7× 49 0.5× 104 1.5× 78 1.2× 12 0.3× 8 398
Santosh D. Bhosale Finland 12 174 1.0× 31 0.3× 27 0.4× 62 0.9× 65 1.4× 20 390
Lijuan Shi China 11 203 1.2× 123 1.3× 36 0.5× 56 0.8× 76 1.6× 24 411
Vince Kornél Grolmusz Hungary 11 128 0.7× 66 0.7× 85 1.2× 54 0.8× 14 0.3× 32 332
Ioannis Koutsounas Greece 12 181 1.1× 92 0.9× 132 1.9× 19 0.3× 29 0.6× 19 365
Palma Aurelia Iacovazzi Italy 12 124 0.7× 64 0.7× 57 0.8× 40 0.6× 104 2.2× 23 349

Countries citing papers authored by Satoru Takashima

Since Specialization
Citations

This map shows the geographic impact of Satoru Takashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoru Takashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoru Takashima more than expected).

Fields of papers citing papers by Satoru Takashima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoru Takashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoru Takashima. The network helps show where Satoru Takashima may publish in the future.

Co-authorship network of co-authors of Satoru Takashima

This figure shows the co-authorship network connecting the top 25 collaborators of Satoru Takashima. A scholar is included among the top collaborators of Satoru Takashima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoru Takashima. Satoru Takashima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Nakagawa, Noriko, et al.. (2023). 537. Safety and Effectiveness of Ensitrelvir for the Treatment of COVID-19 in Japanese Clinical Practice: A Post-marketing Surveillance (Interim Analysis). Open Forum Infectious Diseases. 10(Supplement_2). 2 indexed citations
2.
Inoue, Takeshi, et al.. (2023). Clinical utility of SPECT/CT in a neonate with postoperative chylothorax. Pediatrics International. 65(1). e15567–e15567.
3.
Hussain, Syed A., Wataru Obara, Toshinari Yamasaki, et al.. (2022). A Phase 2 Study of S-588410 Maintenance Monotherapy for Platinum-Treated Advanced or Metastatic Urothelial Carcinoma. Bladder Cancer. 8(2). 179–192. 1 indexed citations
4.
Hussain, Syed A., Nobuaki Shimizu, Wataru Obara, et al.. (2021). Phase II open-label study of S-588410 as maintenance monotherapy after first-line platinum-containing chemotherapy in patients with advanced or metastatic urothelial carcinoma.. Journal of Clinical Oncology. 39(6_suppl). 440–440.
5.
Ikematsu, Hideyuki, Frederick G. Hayden, Keiko Kawaguchi, et al.. (2020). Baloxavir Marboxil for Prophylaxis against Influenza in Household Contacts. New England Journal of Medicine. 383(4). 309–320. 99 indexed citations
6.
Takashima, Satoru, et al.. (2018). A case of hyperinsulinemic hypoglycemia related with a calcimimetic agent. Diabetology International. 9(3). 196–200.
7.
Takashima, Satoru, Hiroki Fujita, Hiromi Fujishima, et al.. (2016). Stromal cell–derived factor-1 is upregulated by dipeptidyl peptidase-4 inhibition and has protective roles in progressive diabetic nephropathy. Kidney International. 90(4). 783–796. 85 indexed citations
8.
Takashima, Satoru, Hajime Saito, Naoko Takahashi, et al.. (2013). Strong expression of cyclin B2 mRNA correlates with a poor prognosis in patients with non-small cell lung cancer. Tumor Biology. 35(5). 4257–4265. 33 indexed citations
9.
Mimae, Takahiro, M. Yamashita, Hiroshi Suehisa, et al.. (2009). [Large cell neuroendocrine carcinoma of the lung].. PubMed. 62(6). 442–5. 1 indexed citations
10.
Takashima, Satoru, et al.. (2004). New Quassinoids, Javanicolides C and D and Javanicosides B−F, from Seeds of Brucea javanica. Journal of Natural Products. 67(5). 863–868. 44 indexed citations
11.
Saeki, Toshiaki, Minoru Tanada, Satoru Takashima, et al.. (1997). Correlation between Expression of Platelet-derived Endothelial Cell Growth Factor (Thymidine Phosphorylase) and Microvessel Density in Early-stage Human Colon Carcinomas. Japanese Journal of Clinical Oncology. 27(4). 227–230. 37 indexed citations
12.
Takashima, Satoru, N. Sato, Yasuaki Tamura, et al.. (1996). Involvement of peptide antigens in the cytotoxicity between 70-kDa heat shock cognate protein-like molecule and CD3+, CD4-, CD8-, TCR-alpha beta- killer T cells. The Journal of Immunology. 157(8). 3391–3395. 22 indexed citations
13.
Tamura, Yasuaki, Satoru Takashima, Kenjiro Kamiguchi, et al.. (1996). Inhibition of Natural Killer Cell Cytotoxicity by Cell Growth‐related Molecules. Japanese Journal of Cancer Research. 87(6). 623–630. 8 indexed citations
14.
Saeki, Toshiaki, et al.. (1996). Differential expression of platelet-derived endothelial cell growth factor (thymidine phosphorylase) in nonpolypoid and polypoid lesions of the colon. International Journal of Oncology. 8(6). 1105–11. 8 indexed citations
15.
Tamura, Yasuaki, et al.. (1994). Transformation‐associated 86 kDa Natural Killer Target Molecule Expressed on the Mouse, Rat and Human Cell Surface. Japanese Journal of Cancer Research. 85(8). 862–868. 3 indexed citations
16.
Saeki, Toshiaki, WJ Gullick, Koichi Mandai, et al.. (1994). EXPRESSION OF CRIPTO-1 IN HUMAN COLORECTAL ADENOMAS AND CARCINOMAS IS RELATED TO THE DEGREE OF DYSPLASIA. International Journal of Oncology. 5(3). 445–51. 8 indexed citations
17.
Saeki, Toshiaki, David S. Salomon, Nicola Normanno, et al.. (1994). IMMUNOHISTOCHEMICAL DETECTION OF CRIPTO-1, AMPHIREGULIN AND TRANSFORMING GROWTH-FACTOR-ALPHA IN HUMAN GASTRIC CARCINOMAS AND INTESTINAL METAPLASIAS. International Journal of Oncology. 5(2). 215–23. 23 indexed citations
18.
Yamakawa, Yasushi, et al.. (1990). [The sensitivity of in situ hybridization for detection of human papillomavirus].. PubMed. 38(11). 1291–4. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caroline T. Seebauer Breakdown of academic impact, for papers by Satoshi Tsunematsu Breakdown of academic impact, for papers by Hitendra S. Solanki Breakdown of academic impact, for papers by José Ortiz Breakdown of academic impact, for papers by Santosh D. Bhosale Breakdown of academic impact, for papers by Lijuan Shi Breakdown of academic impact, for papers by Vince Kornél Grolmusz Breakdown of academic impact, for papers by Ioannis Koutsounas Breakdown of academic impact, for papers by Palma Aurelia Iacovazzi
Rankless by CCL
2026